Yatharth Hospital & Trauma Care Services Ltd.YATHARTH₹831.85 +9.40%

Shares of Yatharth Hospital & Trauma Care Services Ltd. surged over 10% on Tuesday to hit a new 52-week-high of ₹843.70. The rally, which saw the smallcap stock climb past its previous peak, was triggered by an announcement from the Union Health Ministry regarding revised rates for medical procedures.

The surge came after the Union Health Ministry announced a revision of rates for nearly 2,000 medical procedures covered under the Central Government Health Services (CGHS) scheme, with new terms effective October 13.

The new rates introduce a tiered structure designed to incentivize quality and specialization:

  • Consultations at NABH or NABL-accredited hospitals will be reimbursed at a standard base rate.
  • Non-accredited hospitals will receive 15% lower rates.
  • Super-speciality hospitals with over 200 beds will receive a 15% premium (15% higher than the base rate).

CGHS, which provides subsidized medical treatment to approximately 4.6 million government beneficiaries, last saw a major rate overhaul in 2014. The move is expected to benefit quality-focused, accredited hospitals.

About the company

Yatharth Hospital & Trauma Care Services Ltd is one of North India’s leading private super-speciality hospital chains, operating seven facilities with a total capacity of over 2,300 beds across Delhi NCR and Madhya Pradesh.

In Q1FY26, revenue surged 22% YoY to ₹2,578 million. PAT was up 40% YoY to ₹425 million, despite higher depreciation costs associated with recent capacity expansion. The newly operational Greater Faridabad facility turned Net Profit positive in Q1 FY26, demonstrating rapid turnaround capabilities. The company is accelerating growth with an additional 700 new beds in New Delhi and Faridabad, which are set to accelerate growth momentum starting in Q2 FY26.

Since listing, this stock has delivered multibagger returns of more than 175%.

Let’s take a look at its Factor Analysis scores:

Note: The stock price mentioned is as of 3:30 pm.

Disclaimer and Disclosure 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing. Registration granted by SEBI, enlistment as Research Analyst with Exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Kindly refer to  https://share.market/ for more details.Investments in WealthBaskets are subject to the Terms of Service. All investors are advised to conduct their own independent research into investment strategies before making an investment decision. PPWB acts as a distributor of mutual funds and WealthBaskets and it is not an exchange traded product. Disputes with respect to the distribution activity of Mutual Funds and WealthBaskets will not have access to Exchange investor redressal or Arbitration mechanism. The securities are quoted as an example and not as a recommendation. This is for informational purposes and should not be considered as recommendations.

PhonePe Wealth Broking Private Limited is a member of NSE & BSE with SEBI Regn. No.: INZ000302639, Depository Participant of CDSL Depository with SEBI Regn. No.: IN-DP-696-2022, Research Analyst with SEBI Regn No: INH000013387, BSE RA Enlistment Number: 5887 and Mutual Fund distributor with AMFI Registration No: ARN- 187821. Member ID: BSE- 6756, NSE- 90226. Registered office – 2, Floor 3, Wing A, Block A, Salarpuria Softzone, Service Road, Green Glen Layout, Bellandur, Bengaluru South, Bengaluru, Karnataka – 560103, INDIA. CIN: U65990KA2021PTC146954